🇺🇸 FDA
Pipeline program

Dectova 10 mg/mL solution for infusion

200925

Phase 2 small_molecule active

Quick answer

Dectova 10 mg/mL solution for infusion for Influenza, Human is a Phase 2 program (small_molecule) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline Biologicals S.A.
Indication
Influenza, Human
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials